Cargando…
Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy—Long-Term Outcome of a Phase II Pilot Study †
Hilar cholangiocarcinoma (CC) is non-resectable in the majority of patients often due to intrahepatic extension along bile duct branches/segments, and even after complete resection (R0) recurrence can be as high as 70%. Photodynamic therapy (PDT) is an established palliative local tumor ablative tre...
Autores principales: | Wagner, Andrej, Wiedmann, Marcus, Tannapfel, Andrea, Mayr, Christian, Kiesslich, Tobias, Wolkersdörfer, Gernot W., Berr, Frieder, Hauss, Johann, Witzigmann, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661837/ https://www.ncbi.nlm.nih.gov/pubmed/26561801 http://dx.doi.org/10.3390/ijms161125978 |
Ejemplares similares
-
MicroRNAs Associated with the Efficacy of Photodynamic Therapy in Biliary Tract Cancer Cell Lines
por: Wagner, Andrej, et al.
Publicado: (2014) -
The Role of Photodynamic Therapy for Hilar Cholangiocarcinoma
por: Cheon, Young Koog
Publicado: (2010) -
Neoadjuvant therapy in the treatment of hilar cholangiocarcinoma: Review of the literature
por: Frosio, Fabio, et al.
Publicado: (2019) -
Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma
por: Wentrup, Robert, et al.
Publicado: (2016) -
The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
por: Mayr, Christian, et al.
Publicado: (2015)